Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

• Asıl Yazarlar: Nobuo Kanazawa (Yazar), Taeko Ishii (Yazar), Yasushi Takita (Yazar), Atsushi Nishikawa (Yazar), Ryuta Nishikomori (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2023-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background This study evaluated the efficacy and safety of baricitinib (Janus kinase-1/2 inhibitor), in adult and pediatric Japanese patients with Nakajo-Nishimura syndrome/chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (NNS/CANDLE), stimulator of inter...